schizophrenia

News and resources

Month: October 2023

Oct 08 2023

Will New Antipsychotics for Schizophrenia Be Game Changers?

by Clinical Editor

No Comments

In a previous article, I made the case that little has changed within the antipsychotic drug landscape over the past 70 years since the only effective medications for the treatment...

Oct 07 2023

Looking Back on Living With Untreated Schizophrenia

by Clinical Editor

No Comments

My anosognosia story Prior to my diagnosis, I did not realize schizophrenia had dramatically altered my sense of reality. Because of this, I spent four years homeless. I remember when...

Oct 07 2023

Extra-large synapses could be a cause of schizophrenia

by Clinical Editor

No Comments

Schizophrenia may be associated with the excessive formation of oversized and hyperactive synaptic connections between nerves in the brain, a mouse model and a human post-mortem study published in …

Oct 07 2023

Schizophrenia Player BioXcel’s Drug Faces Funding Headwinds, Analyst Downgrades Stock

by Clinical Editor

No Comments

Truist downgraded BioXcel Therapeutics Inc (NASDAQ: BTAI) from Buy to Hold, citing significant near-term funding and …

Oct 07 2023

Man stuck in Clay County jail with schizophrenia transferred to hospital after Star report

by Clinical Editor

No Comments

I want to thank you because I’m convinced that you were instrumental in this move,” the man’s mother wrote in a text to The Star.

Oct 07 2023

Missing Eritrean Man with Schizophrenia Safely Located in Oakland

by Clinical Editor

No Comments

Awot Tara, an Eritrean man classified as missing and at-risk, was successfully located yesterday in a community-based recovery effort.

Oct 06 2023

How Karuna’s schizophrenia med KarXT went from a ‘serendipitous clinical finding’ to the FDA in 25 not-so-short years – FierceBiotech

by Clinical Editor

No Comments

How Karuna’s schizophrenia med KarXT went from a ‘serendipitous clinical finding’ to the FDA in 25 not-so-short years FierceBiotech

Oct 06 2023

Schizophrenia Player BioXcel’s Drug Faces Funding Headwinds, Analyst Downgrades Stock

by Clinical Editor

No Comments

Truist downgraded BioXcel Therapeutics Inc (NASDAQ: BTAI) from Buy to Hold, citing significant near-term funding and …

Oct 06 2023

Extra-large synapses could be a cause of schizophrenia

by Clinical Editor

No Comments

Schizophrenia may be associated with the excessive formation of oversized and hyperactive synaptic connections between nerves in the brain, a mouse model and a human post-mortem study published in …

Oct 06 2023

Man stuck in Clay County jail with schizophrenia transferred to hospital after Star report

by Clinical Editor

No Comments

I want to thank you because I’m convinced that you were instrumental in this move,” the man’s mother wrote in a text to The Star.